Halftime Report

Monday - Friday, 12:00 - 1:00 PM ET
Halftime Report

Top Trader Jon Najarian Bets on a Small-Cap Biotech

Share
VIDEO1:0801:08
Jon Najarian Buys A Biotech on Unusual Activity

After spotting unusual options activity in biopharma name Relypsa, Halftime Report expert Jon Najarian made a move. He breaks down the trade.